Erlotinib for Treatment of Psoriasis
Clinical trial NCT01006096 · WITHDRAWN
Trial details
- NCT number
- NCT01006096
- Sponsor
- Northwestern University
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.